CVD risk assessment: from cholesterol screening to deprescribing statins

Actions Panel

CVD risk assessment: from cholesterol screening to deprescribing statins

For all health professionals

By SAPMEA

Date and time

Tue, 22 Jun 2021 1:30 AM - 3:30 AM PDT

Location

Online

About this event

This workshop will investigate how to perform and interpret cholesterol screening and further clarify prescription of HMG-CoA Reductase inhibitors (statins) with reference to PBS guidelines. This workshop will examine timing and choice of appropriate investigations to reduce the risk of vascular events.

Learning outcomes:

  • Interpret cholesterol screening tests to assess cardiovascular disease risk
  • Establish which investigation to choose, when and for which patient
  • Examine how to prescribe statins to reduce the risk of vascular events

Presented by:

Dr Justin Ardill

CPD Activity Points:

Pending approval for 4 points with RACGP and 2 points with ACCRM

Event Flyer:

Click here to view

Funded by:

Organised by

The South Australian Postgraduate Medical Education Association (SAPMEA) is a charity and not for profit organisation with a principle objective to develop and implement continuing education programs for medical and health professionals.

SAPMEA offers CPD accredited education programs through face-to-face workshops and seminars, as well as online learning.

SAPMEA invests all proceeds directly into medical education and has been doing so since 1897.

Sales Ended